Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) Invested Capital (2016 - 2025)

Sanofi's Invested Capital history spans 17 years, with the latest figure at $104.9 billion for Q4 2025.

  • On a quarterly basis, Invested Capital rose 4.78% to $104.9 billion in Q4 2025 year-over-year; TTM through Mar 2026 was $8.3 billion, a 16.82% decrease, with the full-year FY2025 number at $104.9 billion, up 4.78% from a year prior.
  • Invested Capital hit $104.9 billion in Q4 2025 for Sanofi, up from $8.3 billion in the prior quarter.
  • Over the last five years, Invested Capital for SNY hit a ceiling of $104.9 billion in Q4 2025 and a floor of $2.7 billion in Q2 2021.
  • Historically, Invested Capital has averaged $52.9 billion across 5 years, with a median of $52.9 billion in 2022.
  • Biggest five-year swings in Invested Capital: decreased 26.92% in 2021 and later skyrocketed 94.59% in 2024.
  • Tracing SNY's Invested Capital over 5 years: stood at $101.7 billion in 2021, then fell by 5.73% to $95.9 billion in 2022, then rose by 1.61% to $97.4 billion in 2023, then rose by 2.69% to $100.1 billion in 2024, then grew by 4.78% to $104.9 billion in 2025.
  • Business Quant data shows Invested Capital for SNY at $104.9 billion in Q4 2025, $8.3 billion in Q2 2025, and $100.1 billion in Q4 2024.